Tebapivat
Tebapivat (PKR activator 2) is a potent pyruvate kinase-R (PKR) activator extracted from patent WO2019035863A1, compound 385[1].
Product Specifications
CAS Number
[2283422-04-6]
Product Name Alternative
AG-946; PKR activator 2
UNSPSC
12352005
Target
Pyruvate Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tebapivat.html
Purity
99.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C(N(C)C2=C3SC(CC4=NNC=C4)=N2)=C3C=NN1CC5=NC(N)=CC=C5
Molecular Formula
C18H16N8OS
Molecular Weight
392.44
References & Citations
[1]Giovanni Cianchetta, et al. Pyruvate kinase activators for use in treating blood disorders. WO2019035863A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
D 028-25 5x 5 µmol
2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate), Rp-/Sp-isomers (Rp-/Sp-ddUTP-α-S), sodium salt
Ask
View Details 244541-ML750 100 µL
CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A (Melanoma, p16, inhibits CDK4), ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19) (MaxLight 750) discontinued
Ask
View Details 